10 likes | 20 Views
Global Blood Cancer Drugs Market is segmented By Type (Leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Myeloma), By Drugs Type (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)
E N D